Case File №
#VI-2026-0107
Shanghai JinBei Chemical Technology
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
43 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Tirzepatide | A Great | 9 | 8.6 | 7.4 | 9.8 | 3 Oct 2025 |
| Retatrutide | B Good | 9 | 7.9 | 5.2 | 10.0 | 13 Dec 2025 |
| 1-Benzyl-4-piperidone CAS 3612-20-2 | X N/A | 1 | 10.0 | 10.0 | 10.0 | 21 May 2025 |
| 17a-Methyl-1-Testosterone | X N/A | 1 | 6.4 | 6.4 | 6.4 | 25 Apr 2025 |
| (2-Chloroethyl)benzene CAS 622-24-2 | X N/A | 1 | 10.0 | 10.0 | 10.0 | 2 Apr 2025 |
| 4-Piperidone CAS 41661-47-6 | X N/A | 1 | 10.0 | 10.0 | 10.0 | 9 Jun 2025 |
| AICAR | X N/A | 1 | 10.0 | 10.0 | 10.0 | 27 Feb 2025 |
| Alprostadil | X N/A | 1 | 6.0 | 6.0 | 6.0 | 7 May 2025 |
| Anadrol Oil | X N/A | 1 | 10.0 | 10.0 | 10.0 | 27 Feb 2025 |
| APAA (alpha-phenylacetoacetamide) CAS 102-01-2 | X N/A | 1 | 9.4 | 9.4 | 9.4 | 25 Apr 2025 |
| BAM15 | X N/A | 1 | 7.2 | 7.2 | 7.2 | 3 Jul 2025 |
| Blend 300 (TRA/Mast P/Test P) | X N/A | 1 | 10.0 | 10.0 | 10.0 | 2 Apr 2025 |
| Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | X N/A | 1 | 9.1 | 9.1 | 9.1 | 3 Jun 2025 |
| BPC157 10mg + TB500 10mg Blend | X N/A | 1 | 10.0 | 10.0 | 10.0 | 13 Jun 2025 |
| Bronchogen | X N/A | 1 | 10.0 | 10.0 | 10.0 | 6 May 2025 |
| Cardiogen | X N/A | 1 | 8.4 | 8.4 | 8.4 | 25 Apr 2025 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X N/A | 1 | 8.2 | 8.2 | 8.2 | 9 Jun 2025 |
| Clomid | X N/A | 1 | 5.6 | 5.6 | 5.6 | 2 Apr 2025 |
| DNP | X N/A | 1 | 9.5 | 9.5 | 9.5 | 2 Apr 2025 |
| GHRP-2 Acetate | X N/A | 1 | 8.7 | 8.7 | 8.7 | 16 Mar 2025 |
| GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg | X N/A | 1 | 9.7 | 9.7 | 9.7 | 6 May 2025 |
| Glutathione | X N/A | 1 | 6.0 | 6.0 | 6.0 | 24 Apr 2025 |
| HGH 191AA (Somatropin) | X N/A | 1 | 6.7 | 6.7 | 6.7 | 25 Apr 2025 |
| IGF-1 LR3 | X N/A | 1 | 9.9 | 9.9 | 9.9 | 28 Mar 2025 |
| KPV Oral | X N/A | 1 | 9.4 | 9.4 | 9.4 | 13 Jun 2025 |
| LGD-4033 (Ligandrol) | X N/A | 1 | 10.0 | 10.0 | 10.0 | 2 Apr 2025 |
| Lipo Mino Mix (B6+Methionine+Inositol+Choline+B1+B2+Carnitine) | X N/A | 1 | 6.1 | 6.1 | 6.1 | 24 Apr 2025 |
| Minoxidil Oral | X N/A | 1 | 8.1 | 8.1 | 8.1 | 11 Jun 2025 |
| MT-1 | X N/A | 1 | 8.0 | 8.0 | 8.0 | 16 Mar 2025 |
| NA Semax Amidate | X N/A | 1 | 6.7 | 6.7 | 6.7 | 25 Apr 2025 |
| NAD+ | X N/A | 1 | 7.5 | 7.5 | 7.5 | 7 May 2025 |
| P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 | X N/A | 1 | 8.3 | 8.3 | 8.3 | 13 Feb 2025 |
| Primobolan Oral (Methenolone Acetate) | X N/A | 1 | 9.1 | 9.1 | 9.1 | 2 Jul 2025 |
| PTD-DBM | X N/A | 1 | 6.0 | 6.0 | 6.0 | 11 Jun 2025 |
| Retatrutide Raw | X N/A | 1 | 9.6 | 9.6 | 9.6 | 3 Jun 2025 |
| Salbutamol | X N/A | 1 | 9.1 | 9.1 | 9.1 | 17 Dec 2024 |
| Semax | X N/A | 1 | 7.8 | 7.8 | 7.8 | 3 Jul 2025 |
| SS-31 | X N/A | 1 | 8.8 | 8.8 | 8.8 | 2 Apr 2025 |
| Test Base (No Ester) | X N/A | 1 | 8.4 | 8.4 | 8.4 | 13 Feb 2025 |
| Thymosin Alpha-1 | X N/A | 1 | 8.0 | 8.0 | 8.0 | 21 May 2025 |
| TriTren 225 | X N/A | 1 | 7.3 | 7.3 | 7.3 | 20 Jun 2025 |
| Vesugen | X N/A | 1 | 9.5 | 9.5 | 9.5 | 3 Jun 2025 |
| Winstrol Oil | X N/A | 1 | 8.8 | 8.8 | 8.8 | 2 Apr 2025 |
Exhibit II
Evidence Log
48 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | 4-Piperidone CAS 41661-47-6 | 10.0 A | 500g | 555.9g | +11.2% | 98.46% | jl7hlb | Lab A | Community |
| 25 May 2026 | GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg | 10.0 A | 2mg | 2.2mg | +10.6% | 95.17% | wxdz1u | Lab C | Community |
| 25 May 2026 | HGH 191AA (Somatropin) | 6.5 A | 30mg | 33.1mg | +10.2% | 95.19% | wncnfc | Lab C | Public |
| 24 May 2026 | AICAR | 9.1 A | 2mg | 2.5mg | +23.6% | 98.33% | az7t5b | Lab F | Public |
| 24 May 2026 | Retatrutide | 8.0 A | 15mg | 15.5mg | +3.3% | 99.90% | (no batch ID) | Lab E | Public |
| 24 May 2026 | BAM15 | 8.7 A | 50mg | 59.6mg | +19.2% | 98.33% | tddkgf | Lab D | Public |
| 21 May 2026 | Tirzepatide | 8.9 A | 60mg | 55.8mg | -7.0% | 99.74% | 1/2/26 | Lab E | Public |
| 21 May 2026 | Test Base (No Ester) | 5.6 B | 300mg/ml | 271.8mg/ml | -9.4% | 97.83% | 6jd7uo | Lab B | Public |
| 21 May 2026 | Thymosin Alpha-1 | 7.6 A | 30mg | 35.3mg | +17.7% | 95.04% | o1if6f | Lab G | Public |
| 21 May 2026 | Blend 300 (TRA/Mast P/Test P) | 10.0 A | 300mg/ml | 328.4mg/ml | +9.5% | 98.46% | x29664 | Lab F | Community |
| 19 May 2026 | PTD-DBM | 7.1 A | 15mg | 18.0mg | +19.9% | 96.73% | va1x4i | Lab C | Public |
| 17 May 2026 | Retatrutide | 7.8 A | 20mg | 20.4mg | +2.0% | 99.80% | (no batch ID) | Lab G | Public |
| 17 May 2026 | Tirzepatide | 7.9 A | 40mg | 41.4mg | +3.5% | 98.93% | SHJN-11172025 | Lab E | Public |
| 17 May 2026 | Tirzepatide | 8.4 A | 60mg | 61mg | +1.7% | 99.19% | SHJN-11172025 | Lab E | Public |
| 17 May 2026 | Tirzepatide | 8.2 A | 20mg | 18.2mg | -9.0% | 99.67% | 12/29/2025 | Lab E | Public |
| 17 May 2026 | Tirzepatide | 8.3 A | 20mg | 20.5mg | +2.5% | 99.16% | SHJN-11172025 | Lab E | Public |
| 29 Jan 2026 | LGD-4033 (Ligandrol) | 10.0 A | 50mg | 53.0mg | +5.9% | 95.78% | r2k7b1 | Lab G | Public |
| 29 Jan 2026 | Primobolan Oral (Methenolone Acetate) | 10.0 A | 25mg | 24.0mg | -4.0% | 98.85% | 6b63yt | Lab G | Community |
| 26 Jan 2026 | NA Semax Amidate | 5.0 B | 30mg | 32.5mg | +8.5% | 95.22% | 8wiv81 | Lab E | Public |
| 19 Jan 2026 | 1-Benzyl-4-piperidone CAS 3612-20-2 | 10.0 A | 500g | 619.0g | +23.8% | 97.70% | 0z1ioe | Lab F | Public |
| 19 Jan 2026 | (2-Chloroethyl)benzene CAS 622-24-2 | 9.3 A | 10g | 9.2g | -7.6% | 99.45% | i29bhd | Lab B | Community |
| 19 Jan 2026 | Bronchogen | 8.9 A | 5mg | 5.3mg | +6.2% | 98.98% | phiieo | Lab F | Community |
| 19 Jan 2026 | Salbutamol | 10.0 A | 10mg | 8.8mg | -12.4% | 99.60% | mz4r19 | Lab A | Public |
| 9 Jan 2026 | Cardiogen | 10.0 A | 10mg | 9.5mg | -4.6% | 97.94% | i6xq5m | Lab A | Public |
| 9 Jan 2026 | Clomid | 6.6 A | 25mg | 23.2mg | -7.2% | 99.11% | 4qrm98 | Lab C | Public |
| 9 Jan 2026 | P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 | 10.0 A | 1g | 1.2g | +21.9% | 98.88% | z4arvl | Lab D | Community |
| 7 Jan 2026 | Semax | 5.4 B | 10mg | 9.4mg | -5.5% | 97.10% | lm38eo | Lab C | Community |
| 6 Jan 2026 | Minoxidil Oral | 8.0 A | 100mg | 118.9mg | +18.9% | 95.75% | 2fkr7c | Lab E | Community |
| 29 Dec 2025 | DNP | 10.0 A | 100mg | 91.5mg | -8.5% | 95.77% | qqrwmz | Lab G | Public |
| 12 Dec 2025 | 17a-Methyl-1-Testosterone | 4.6 C | 25mg | 29.3mg | +17.3% | 95.09% | ecide8 | Lab B | Community |
| 12 Dec 2025 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 6.9 A | 5mg | 5.7mg | +14.6% | 97.31% | jjnjuu | Lab D | Public |
| 12 Dec 2025 | KPV Oral | 9.9 A | 25mg | 28.1mg | +12.4% | 96.17% | 5jmtp8 | Lab G | Public |
| 12 Dec 2025 | TriTren 225 | 7.9 A | 200mg/ml | 228.8mg/ml | +14.4% | 95.49% | bhl5ld | Lab G | Public |
| 5 Dec 2025 | IGF-1 LR3 | 8.7 A | 30mg | 36.8mg | +22.5% | 99.32% | pjqzww | Lab G | Public |
| 5 Dec 2025 | MT-1 | 9.6 A | 15mg | 16.2mg | +8.2% | 97.14% | f9dgcb | Lab B | Public |
| 23 Nov 2025 | Alprostadil | 6.3 A | 50mg | 50.3mg | +0.6% | 95.03% | h57ym9 | Lab D | Community |
| 23 Nov 2025 | Anadrol Oil | 8.2 A | 300mg/ml | 291.2mg/ml | -2.9% | 97.71% | 1p9tc4 | Lab F | Public |
| 23 Nov 2025 | BPC157 10mg + TB500 10mg Blend | 10.0 A | 10mg | 10.2mg | +2.4% | 99.62% | f49gqc | Lab D | Public |
| 23 Nov 2025 | Winstrol Oil | 8.6 A | 200mg/ml | 206.7mg/ml | +3.4% | 98.36% | 4f8gvd | Lab B | Community |
| 14 Nov 2025 | APAA (alpha-phenylacetoacetamide) CAS 102-01-2 | 7.5 A | 500g | 460.4g | -7.9% | 97.08% | cmk0ur | Lab A | Community |
| 14 Nov 2025 | Lipo Mino Mix (B6+Methionine+Inositol+Choline+B1+B2+Carnitine) | 5.0 B | 300mg/ml | 361.0mg/ml | +20.3% | 98.85% | 3nhlm4 | Lab G | Community |
| 5 Nov 2025 | Vesugen | 10.0 A | 15mg | 17.4mg | +15.9% | 99.14% | z0sw5v | Lab C | Public |
| 4 Nov 2025 | GHRP-2 Acetate | 9.7 A | 15mg | 13.6mg | -9.5% | 95.16% | ndee3p | Lab B | Public |
| 4 Nov 2025 | Glutathione | 7.0 A | 50mg | 59.9mg | +19.8% | 98.05% | w491ei | Lab B | Public |
| 17 Oct 2025 | Retatrutide Raw | 10.0 A | 500g | 443.5g | -11.3% | 99.34% | vka0ax | Lab E | Public |
| 9 Oct 2025 | NAD+ | 9.1 A | 15mg | 17.1mg | +14.0% | 95.38% | zs9hcx | Lab C | Public |
| 9 Oct 2025 | SS-31 | 7.2 A | 5mg | 6.2mg | +24.8% | 98.04% | kfcyrh | Lab G | Public |
| 3 Oct 2025 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 7.9 A | 300mg/ml | 331.5mg/ml | +10.5% | 95.97% | 3vswjr | Lab A | Public |
— END OF EVIDENCE LOG —